282 related articles for article (PubMed ID: 30609023)
1. Curcumin as a therapeutic agent in leukemia.
Kouhpeikar H; Butler AE; Bamian F; Barreto GE; Majeed M; Sahebkar A
J Cell Physiol; 2019 Aug; 234(8):12404-12414. PubMed ID: 30609023
[TBL] [Abstract][Full Text] [Related]
2. The Multifaceted Role of Curcumin in Advanced Nanocurcumin Form in the Treatment and Management of Chronic Disorders.
Tagde P; Tagde P; Islam F; Tagde S; Shah M; Hussain ZD; Rahman MH; Najda A; Alanazi IS; Germoush MO; Mohamed HRH; Algandaby MM; Nasrullah MZ; Kot N; Abdel-Daim MM
Molecules; 2021 Nov; 26(23):. PubMed ID: 34885693
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research.
Jurenka JS
Altern Med Rev; 2009 Jun; 14(2):141-53. PubMed ID: 19594223
[TBL] [Abstract][Full Text] [Related]
4. Antitumor Activity of Curcumin in Glioblastoma.
Walker BC; Mittal S
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322413
[TBL] [Abstract][Full Text] [Related]
5. The molecular mechanisms of curcumin's inhibitory effects on cancer stem cells.
Zendehdel E; Abdollahi E; Momtazi-Borojeni AA; Korani M; Alavizadeh SH; Sahebkar A
J Cell Biochem; 2019 Apr; 120(4):4739-4747. PubMed ID: 30269360
[TBL] [Abstract][Full Text] [Related]
6. Effect of pure curcumin, demethoxycurcumin, and bisdemethoxycurcumin on WT1 gene expression in leukemic cell lines.
Anuchapreeda S; Tima S; Duangrat C; Limtrakul P
Cancer Chemother Pharmacol; 2008 Sep; 62(4):585-94. PubMed ID: 18034345
[TBL] [Abstract][Full Text] [Related]
7. Curcumin: a Polyphenol with Molecular Targets for Cancer Control.
Qadir MI; Naqvi ST; Muhammad SA
Asian Pac J Cancer Prev; 2016; 17(6):2735-9. PubMed ID: 27356682
[TBL] [Abstract][Full Text] [Related]
8. Curcumin: the story so far.
Sharma RA; Gescher AJ; Steward WP
Eur J Cancer; 2005 Sep; 41(13):1955-68. PubMed ID: 16081279
[TBL] [Abstract][Full Text] [Related]
9. Deciphering the molecular mechanistic paths describing the chemotherapeutic potential and epigenetic regulation of curcumin in lung cancer: a mini review.
Karati D; Mukherjee S; Roy S
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):2715-2725. PubMed ID: 37982888
[TBL] [Abstract][Full Text] [Related]
10. Potential Mechanisms of Action of Curcumin for Cancer Prevention: Focus on Cellular Signaling Pathways and miRNAs.
Wang M; Jiang S; Zhou L; Yu F; Ding H; Li P; Zhou M; Wang K
Int J Biol Sci; 2019; 15(6):1200-1214. PubMed ID: 31223280
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Effects of Curcumin-From Traditional Past to Present and Future Clinical Applications.
Bachmeier BE; Melchart D
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31374813
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Potential of Curcumin for the Treatment of Brain Tumors.
Klinger NV; Mittal S
Oxid Med Cell Longev; 2016; 2016():9324085. PubMed ID: 27807473
[TBL] [Abstract][Full Text] [Related]
13. Curcumin in Cancer and Inflammation: An In-Depth Exploration of Molecular Interactions, Therapeutic Potentials, and the Role in Disease Management.
Moon DO
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474160
[TBL] [Abstract][Full Text] [Related]
14. Curcumin and its promise as an anticancer drug: An analysis of its anticancer and antifungal effects in cancer and associated complications from invasive fungal infections.
Chen J; He ZM; Wang FL; Zhang ZS; Liu XZ; Zhai DD; Chen WD
Eur J Pharmacol; 2016 Feb; 772():33-42. PubMed ID: 26723514
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapeutic potential of curcumin for colorectal cancer.
Chauhan DP
Curr Pharm Des; 2002; 8(19):1695-706. PubMed ID: 12171541
[TBL] [Abstract][Full Text] [Related]
16. Curcumin and chemokines: mechanism of action and therapeutic potential in inflammatory diseases.
Sadeghi M; Dehnavi S; Asadirad A; Xu S; Majeed M; Jamialahmadi T; Johnston TP; Sahebkar A
Inflammopharmacology; 2023 Jun; 31(3):1069-1093. PubMed ID: 36997729
[TBL] [Abstract][Full Text] [Related]
17. Development of curcumin as an epigenetic agent.
Fu S; Kurzrock R
Cancer; 2010 Oct; 116(20):4670-6. PubMed ID: 20597137
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological properties and underlying mechanisms of curcumin and prospects in medicinal potential.
Fu YS; Chen TH; Weng L; Huang L; Lai D; Weng CF
Biomed Pharmacother; 2021 Sep; 141():111888. PubMed ID: 34237598
[TBL] [Abstract][Full Text] [Related]
19. Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications.
Bar-Sela G; Epelbaum R; Schaffer M
Curr Med Chem; 2010; 17(3):190-7. PubMed ID: 20214562
[TBL] [Abstract][Full Text] [Related]
20. Current evidence and future perspectives for curcumin and its analogues as promising adjuncts to oxaliplatin: state-of-the-art.
Zangui M; Atkin SL; Majeed M; Sahebkar A
Pharmacol Res; 2019 Mar; 141():343-356. PubMed ID: 30641277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
